We invite you to test your knowledge in these two interactive case studies in both first- and
second-line settings.

Part 1 New Options in metastatic cancer: first-line treatment
Part 2 New Options in metastatic cancer: second-line treatment

To start, please click the images below:

About pancreatic cancer

Faculty bio

• Thomas Seufferlein

Learning objectives

After participating in these interactive patient case studies, the learner will be able to:

• Select the most appropriate treatment approach for newly diagnosed metastatic PDAC based on patient and disease characteristics
• Identify optimal treatment strategies for patients with progressive PDAC (second line therapy and beyond)
• Describe the current and potential use of biomarkers in PDAC

Target audience

These two case studies are intended for global medical, surgical and radiation oncologists, gastroenterologists, and other healthcare providers involved in the management of patients with pancreatic cancer, and any other clinicians involved in the diagnosis, treatment and follow-up of patients with PDAC.

Educational grant

Developed with an independent educational grant from Shire and supported by Servier.

Produced by Springer Healthcare IME.

C​​ontact us

Email: IME@springer.com

Telephone +44 (0) 203 192 2023
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK